Patent Number: 8,088,941

Title: Glycogen synthase kinase-3 inhibitors

Abstract: Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions.

Inventors: Eldar-Finkelman; Hagit (Shoham, IL), Portnoy; Moshe (Givat Shmuel, IL)

Assignee: Tel Aviv University Future Technology Development L.P.

International Classification: C07F 9/02 (20060101); A61K 31/155 (20060101)

Expiration Date: 2020-01-03 0:00:00